Dual anticoagulation with fondaparinux and dabigatran for treatment of cancer-associated hypercoagulability

Am J Hematol. 2018 Jun;93(6):E156-E158. doi: 10.1002/ajh.25101. Epub 2018 Apr 18.
No abstract available

Keywords: Dual anticoagulation; cancer and thrombosis; dabigatran; fondaparinux; venous thromboembolism.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use*
  • Antithrombins / therapeutic use
  • Dabigatran / therapeutic use
  • Drug Therapy, Combination / methods*
  • Factor Xa Inhibitors / therapeutic use
  • Fondaparinux / therapeutic use
  • Humans
  • Lung Neoplasms / complications*
  • Male
  • Recurrence
  • Thrombophilia / drug therapy*
  • Thrombosis / drug therapy
  • Venous Thromboembolism / drug therapy

Substances

  • Anticoagulants
  • Antithrombins
  • Factor Xa Inhibitors
  • Dabigatran
  • Fondaparinux